Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 31 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
301 21.5 months metastatic colorectal cancer 5 Chemotherapy
University General Hospital of Heraklion Greece 2/2006
Treatment Details: Patients: This Phase III study involved 285 patients with metastatic colorectal cancer. The patients were randomly divided into two groups. Group B had 137 patients (76 men, 61 women) wit
 
302 21.5 months NHL 5 Immunotherapy
Medical University of South Carolina United States 3/2015
Treatment Details: Patients: This phase 2 study involved 21 previously treated chronic lymphocytic leukemia and small lymphocytic lymphoma patients. The median patient age was 63 years and 81% were male.
 
303 21.5 months Metastatic, castration-resistant prostate cancer 5 Chemotherapy
Hormone
Thomas Jefferson University United States 3/2012
Treatment Details: Patients: This phase III study involved men with previously untreated (other than surgery) metastatic castration-resistant prostate cancer who were divided into two separate treatment group
 
304 21.5 months Metastatic, castration-resistant prostate cancer 5 Biologic therapy
Chemotherapy
The University of Texas MD Anderson Cancer Center United States 12/2013
Treatment Details: Patients: This phase 3 study involved chemotherapy-naive, metastatic, castration-resistant prostate cancer patients who were divided into two separate treatment groups. Group A consisted o
 
305 21.4 months Metastatic colorectal adenocarcinoma 5 Biologic therapy
Chemotherapy
David Geffen School of Medicine at University of California, Los Angeles United States 5/2011
Treatment Details: Patients: This phase 3 study involved metastatic colorectal adenocarcinoma patients who were divided into two separate treatment groups. Group A consisted of 585 patients with an average a
 
306 21.4 months NHL 4 Biologic therapy
Chemotherapy
University Hospitals Case Medical Center United States 8/2009
Treatment Details: Patients: This study involved 14 patients with non-Hodgkin’s lymphoma who had relapsed after stem cell transplantation. The median patient age was 57 years and 9 were male. Treatment:
 
307 21.4 months Muscle-invasive bladder cancer 4 Chemotherapy
Anticancer Hospital Greece 2/2012
Treatment Details: Patients: This phase II study involved 60 patients with muscle-invasive bladder cancer who had not received prior chemotherapy. The median patient age was 65.5 years 96.7% were male. T
 
308 21.3 months Metastatic colorectal carcinoma 5 Biologic therapy
Chemotherapy
Martin Luther University Halle-Wittenberg Germany 10/2012
Treatment Details: Patients: This phase 3 study involved untreated metastatic colorectal cancer patients who were divided into two separate treatment groups. Group A consisted of 709 patients with a median a
 
309 21.2 months Metastatic, castration-resistant prostate cancer 5 Chemotherapy
The University of Texas MD Anderson Cancer Center United States 12/2013
Treatment Details: Patients: This phase 3 study involved chemotherapy-naive, metastatic, castration-resistant prostate cancer patients who were divided into two separate treatment groups. Group A consisted o
 
310 21.2 months Cutaneous T-cell lymphoma 5 Chemotherapy
University of Manchester United Kingdom 11/2013
Treatment Details: Patients: This phase 2 study involved 36 previously treated cutaneous T-cell lymphoma patients. The median patient age was 65 years and 69.4% were male. Treatment: Patients were treate
 
Page 31 of 187  | Previous Page  | Next Page